| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.29 | 0.1 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.28 | 0.09 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.25 | 0.1 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.24 | 0.07 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.24 | 0.02 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.23 | 0.06 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.22 | 0.2 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.1 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.18 | 0.1 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.18 | 8e-07 |